Research into improving dental outcomes for orthodontic patients is gaining momentum as a clinical trial explores the effectiveness of hydroxyapatite toothpaste and mouthwash in preventing white spot lesions. This study, under the sponsorship of Heba Tahseen Almasri, is currently recruiting participants.
What is the study about?
White spot lesions are a common concern for individuals undergoing orthodontic treatment. These lesions, caused by localized demineralization of tooth enamel, can detract from oral aesthetics and long-term dental health. The ongoing research aims to evaluate whether hydroxyapatite, a biomimetic material replicating the natural composition of enamel, can offer effective protection against these lesions.
What interventions and objectives are included?
Overview of the interventions
The trial involves three groups, each receiving a different combination of dental care products during orthodontic treatment:
- Hydroxyapatite Toothpaste: A dietary supplement toothpaste designed to mimic and restore enamel structures.
- Hydroxyapatite Mouthwash: A complementary product enhancing enamel remineralization.
- Control Group with Fluoride Toothpaste and Placebo Mouthwash: Serving as a baseline comparison for the hydroxyapatite interventions.
Intended objectives and outcomes
The primary goal is to analyze the preventive capability of hydroxyapatite formulations compared to traditional fluoride treatments. Performance will be assessed through clinical observations of lesion development, alongside any potential safety concerns or adverse effects. This comparison could provide new insights into advancing dental care for orthodontic patients.
What is the current status?
The clinical trial, registered with ClinicalTrials.gov, is actively recruiting participants. The study is targeted toward orthodontic patients specifically at risk of developing white spot lesions due to their treatment. For those interested in participating or learning more about the trial’s design, further information is available on the official ClinicalTrials.gov website.
FAQ
- What is hydroxyapatite?
Hydroxyapatite is a naturally occurring mineral and a key component of tooth enamel and bone. In dentistry, it is used to restore enamel and prevent demineralization.
- Who can participate in the trial?
The trial is recruiting individuals undergoing orthodontic treatment and at risk of developing white spot lesions, subject to meeting eligibility criteria.
- Where can I find more details?
You can learn more about the trial, including its objectives and recruiting status, by visiting the ClinicalTrials.gov page linked below.
Conclusion
The ongoing clinical trial reflects a significant step in dental innovation, offering the potential for improved strategies in managing white spot lesions. Orthodontic patients, dental professionals, and researchers should closely monitor this study to understand its outcomes and implications for future dental care best practices.
Disclaimer
This post is intended for informational purposes only and is not legal or medical advice. Always consult with a professional for specific guidance.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07325643?term=medical+device